Akebia Therapeutics Inc

MA · United States · Reporting entity ID 100000521827

Total reported 2019–2025

$89.4M

#105 of 2,960 reporting companies — 0.1% of all reported industry payments

$6.09M in general payments across 39,690 records, plus $83.3M in research funding across 61,492 records.

How it breaks down

General payments $6,086,254

Research funding $83,274,264

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.